• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利东北部弗留利-威尼斯朱利亚地区 2002-2014 年肌萎缩侧索硬化症的流行病学:一项基于人群的回顾性研究。

Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002-2014: a retrospective population-based study.

机构信息

a Medical Area Department , University of Udine , Udine , Italy.

b Neurologic Clinic, Department of Medical, Surgical and Health Sciences , Azienda Sanitaria Universitaria Integrata di Trieste, University Hospital of Trieste , Trieste , Italy.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):90-99. doi: 10.1080/21678421.2018.1511732. Epub 2018 Nov 15.

DOI:10.1080/21678421.2018.1511732
PMID:30430867
Abstract

OBJECTIVES

To describe the epidemiology of Amyotrophic Lateral Sclerosis (ALS) in Friuli-Venezia Giulia (FVG) region, Italy, over a 13-year period (2002-2014), estimating ALS (a) incidence, prevalence, and clinical features; (b) mortality, also comparing Udine municipality to the rest of FVG.

METHODS

We conducted a retrospective population-based study. ALS incident cases were ascertained using multiple sources and validated through expert review. We calculated crude and standardized incidence rate (IR), point prevalence and mortality rate (MR), each with 95% confidence interval. Standardized incidence (SIR) and mortality (SMR) ratio were calculated to compare Udine to FVG.

RESULTS

Among 444 incident cases (50.0% men, median age 68.5 years), onset was bulbar in 30.2%, spinal in 59.9%, mixed in 9.9%; 3.6% had familial ALS. Crude and 2000 European population standardized IR was respectively 2.81 (2.56-3.09) and 2.09 (1.89-2.29) per 100,000 person-years. Standardized male-to-female incidence ratio was 1.05. IR peaked at age 65-74 years (men: 9.93, 8.04-12.32; women: 7.74, 6.18-9.67) and decreased thereafter. Prevalence was 8.36 (6.74-9.97) cases per 100,000 inhabitants on 30 June 2009 and 7.98 (6.40-9.56) on 30 June 2014. SIR was 1.20 and SMR 1.11.

CONCLUSIONS

When assessed over a long period, incidence of ALS was in the range of Italian and European population-based registries and showed a consistent pattern by age and sex. IR and MR were only slightly higher in Udine vs. FVG.

摘要

目的

描述意大利弗留利-威尼斯朱利亚(FVG)地区 13 年来(2002-2014 年)肌萎缩侧索硬化症(ALS)的流行病学情况,估计 ALS 的(a)发病率、患病率和临床特征;(b)死亡率,并将乌迪内市与 FVG 其他地区进行比较。

方法

我们进行了一项回顾性的基于人群的研究。使用多种来源确定 ALS 发病例,并通过专家审查进行验证。我们计算了粗发病率和标准化发病率(IR)、点患病率和死亡率(MR),每个值都有 95%置信区间。计算标准化发病率(SIR)和死亡率(SMR)比值,以比较乌迪内与 FVG。

结果

在 444 例发病例中(50.0%为男性,中位年龄 68.5 岁),发病形式为延髓性 30.2%,脊髓性 59.9%,混合性 9.9%;3.6%为家族性 ALS。粗发病率和 2000 年欧洲人口标准化发病率分别为 2.81(2.56-3.09)和 2.09(1.89-2.29)/10 万人年。标准化男女发病率比值为 1.05。发病率在 65-74 岁年龄组达到高峰(男性:9.93,8.04-12.32;女性:7.74,6.18-9.67),此后逐渐下降。2009 年 6 月 30 日的患病率为每 10 万人 8.36(6.74-9.97)例,2014 年 6 月 30 日为 7.98(6.40-9.56)例。SIR 为 1.20,SMR 为 1.11。

结论

从长期来看,ALS 的发病率在意大利和欧洲基于人群的登记处范围内,且呈年龄和性别一致的模式。乌迪内与 FVG 相比,IR 和 MR 仅略高。

相似文献

1
Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002-2014: a retrospective population-based study.意大利东北部弗留利-威尼斯朱利亚地区 2002-2014 年肌萎缩侧索硬化症的流行病学:一项基于人群的回顾性研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):90-99. doi: 10.1080/21678421.2018.1511732. Epub 2018 Nov 15.
2
The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study.意大利弗留利-威尼斯朱利亚地区 2002 年至 2009 年肌萎缩侧索硬化症的发病率:一项回顾性基于人群的研究。
Neuroepidemiology. 2013;41(1):54-61. doi: 10.1159/000350015. Epub 2013 May 25.
3
[Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].[新冠疫情对弗留利-威尼斯朱利亚大区(意大利北部)的影响:通过竞争风险分析评估与死亡风险相关的因素]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):128-135. doi: 10.19191/EP20.5-6.S2.111.
4
COVID-19 infections in the Friuli Venezia Giulia Region (Northern Italy): a population-based retrospective analysis.意大利北部弗留利-威尼斯朱利亚地区(Friuli Venezia Giulia Region)的 COVID-19 感染:一项基于人群的回顾性分析。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):323-329. doi: 10.19191/EP20.5-6.S2.133.
5
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register.意大利利古里亚地区肌萎缩侧索硬化症的临床流行病学:LIGALS登记册的更新
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct-Nov;17(7-8):535-542. doi: 10.1080/21678421.2016.1197942. Epub 2016 Jul 11.
6
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.意大利南部肌萎缩侧索硬化症的发病率:一项基于人群的研究。
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1094-8. doi: 10.1136/jnnp.2004.039180.
7
Epidemiology of ALS in Italy: a 10-year prospective population-based study.意大利肌萎缩侧索硬化症的流行病学:一项基于人群的10年前瞻性研究。
Neurology. 2009 Feb 24;72(8):725-31. doi: 10.1212/01.wnl.0000343008.26874.d1.
8
Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.肌萎缩侧索硬化症的长期趋势:皮埃蒙特和瓦莱达奥斯塔登记处
JAMA Neurol. 2017 Sep 1;74(9):1097-1104. doi: 10.1001/jamaneurol.2017.1387.
9
Incidence and prevalence of Amyotrophic Lateral Sclerosis in three Italian Regions: a study based on health administrative databases.意大利三个地区肌萎缩侧索硬化症的发病率和患病率:基于健康管理数据库的研究。
Epidemiol Prev. 2024 May-Jun;48(3):201-209. doi: 10.19191/EP24.3.A710.055.
10
Clinical epidemiology of ALS in Liguria, Italy.意大利利古里亚地区肌萎缩侧索硬化症的临床流行病学研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Jan;14(1):52-7. doi: 10.3109/17482968.2012.729062. Epub 2012 Oct 3.

引用本文的文献

1
Genetic epidemiology of amyotrophic lateral sclerosis in Cyprus: a population-based study.塞浦路斯肌萎缩侧索硬化症的遗传流行病学:一项基于人群的研究。
Sci Rep. 2024 Dec 28;14(1):30781. doi: 10.1038/s41598-024-80851-y.
2
Incidence and mortality of ALS: a 42-year population-based nationwide study.肌萎缩侧索硬化症的发病率和死亡率:一项基于全国人口的42年研究。
J Neurol. 2024 Dec 12;272(1):44. doi: 10.1007/s00415-024-12743-0.
3
Racial Disparities in the Diagnosis and Prognosis of ALS Patients in the United States.美国肌萎缩侧索硬化症患者诊断与预后的种族差异
J Racial Ethn Health Disparities. 2024 Jul 25. doi: 10.1007/s40615-024-02099-6.
4
Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients.导致希腊患者散发性肌萎缩侧索硬化的新型致病性变异。
Genes (Basel). 2024 Feb 28;15(3):309. doi: 10.3390/genes15030309.
5
Increased incidence of motor neuron disease in Sweden: a population-based study during 2002-2021.瑞典运动神经元病发病率上升:一项基于2002年至2021年人口的研究。
J Neurol. 2024 May;271(5):2730-2735. doi: 10.1007/s00415-024-12219-1. Epub 2024 Feb 22.
6
The influence of environmental risk factors in the development of ALS in the Mediterranean Island of Cyprus.地中海岛国塞浦路斯环境风险因素对肌萎缩侧索硬化症发病的影响。
Front Neurol. 2023 Nov 23;14:1264743. doi: 10.3389/fneur.2023.1264743. eCollection 2023.
7
Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms.调控肌萎缩侧索硬化症皮质兴奋性过高:聚焦于神经胶质机制。
Mol Neurodegener. 2023 Oct 19;18(1):75. doi: 10.1186/s13024-023-00665-w.
8
Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症运动系统损伤的病理机制网络。
Curr Neuropharmacol. 2024;22(11):1778-1806. doi: 10.2174/1570159X21666230824091601.
9
The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study.鞘内注射自体骨髓间充质基质细胞治疗肌萎缩侧索硬化症的疗效与安全性:一项初步研究。
Adv Pharm Bull. 2023 Mar;13(2):361-367. doi: 10.34172/apb.2023.043. Epub 2022 Jan 8.
10
Epidemiology of amyotrophic lateral sclerosis in the north east Tuscany in the 2018-2021 period.2018 - 2021年期间托斯卡纳东北部肌萎缩侧索硬化症的流行病学
eNeurologicalSci. 2023 Mar 23;31:100457. doi: 10.1016/j.ensci.2023.100457. eCollection 2023 Jun.